# Host Dendritic Cells in Allograft Patients

> **NCT00935597** · PHASE1 · UNKNOWN · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 25 (estimated)

## Conditions studied

- Relapsed Non-Hodgkin's Lymphoma
- Hodgkin's Disease
- Multiple Myeloma
- Chronic Lymphocytic Lymphoma

## Interventions

- **BIOLOGICAL:** MSSM/BIIR HDC Vax-001 (Host Dendritic Cells)

## Key facts

- **NCT ID:** NCT00935597
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2013-07
- **Final completion:** —
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2010-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935597, "Host Dendritic Cells in Allograft Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00935597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*